1. Home
  2. STVN vs HXL Comparison

STVN vs HXL Comparison

Compare STVN & HXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • HXL
  • Stock Information
  • Founded
  • STVN 1949
  • HXL 1946
  • Country
  • STVN Italy
  • HXL United States
  • Employees
  • STVN N/A
  • HXL N/A
  • Industry
  • STVN Containers/Packaging
  • HXL Major Chemicals
  • Sector
  • STVN Consumer Discretionary
  • HXL Industrials
  • Exchange
  • STVN Nasdaq
  • HXL Nasdaq
  • Market Cap
  • STVN 6.2B
  • HXL 5.1B
  • IPO Year
  • STVN 2021
  • HXL N/A
  • Fundamental
  • Price
  • STVN $19.02
  • HXL $59.47
  • Analyst Decision
  • STVN Buy
  • HXL Hold
  • Analyst Count
  • STVN 3
  • HXL 14
  • Target Price
  • STVN $29.33
  • HXL $71.62
  • AVG Volume (30 Days)
  • STVN 633.0K
  • HXL 923.8K
  • Earning Date
  • STVN 11-05-2024
  • HXL 10-21-2024
  • Dividend Yield
  • STVN 0.31%
  • HXL 1.01%
  • EPS Growth
  • STVN N/A
  • HXL N/A
  • EPS
  • STVN 0.48
  • HXL 1.30
  • Revenue
  • STVN $1,220,254,294.00
  • HXL $1,886,700,000.00
  • Revenue This Year
  • STVN $3.01
  • HXL $8.05
  • Revenue Next Year
  • STVN $7.78
  • HXL $8.64
  • P/E Ratio
  • STVN $39.99
  • HXL $45.94
  • Revenue Growth
  • STVN 3.53
  • HXL 7.14
  • 52 Week Low
  • STVN $16.56
  • HXL $57.50
  • 52 Week High
  • STVN $34.73
  • HXL $77.09
  • Technical
  • Relative Strength Index (RSI)
  • STVN 43.43
  • HXL 42.57
  • Support Level
  • STVN $17.12
  • HXL $60.88
  • Resistance Level
  • STVN $22.07
  • HXL $62.54
  • Average True Range (ATR)
  • STVN 1.37
  • HXL 1.38
  • MACD
  • STVN -0.05
  • HXL -0.12
  • Stochastic Oscillator
  • STVN 21.48
  • HXL 23.95

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About HXL Hexcel Corporation

Founded in 1948, Hexcel designs and manufactures a range of highly engineered composite fibers, fabrics, resins, and structures for use in commercial aerospace, defense, and other industrial markets. These are lighter than metal and perform under rigorous conditions in aircraft frames, wings, engines, and other components and subassemblies. The company's name derives from the six-sided honeycomb structures that lend many of its products their light weight and rigidity. Hexcel's biggest customers are Airbus (38% of 2022 sales) and Boeing (25% of prepandemic sales) and its respective subcontractors.

Share on Social Networks: